Search research articles
Contact Us
Filters
Showing results (311-320 of 362) with videos related to
Page
of 37
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 9, 2024
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study
Raymond L Benza, Gérald Simonneau, Hossein-Ardeschir Ghofrani, et al.
The European Respiratory Journal
|
September 11, 2017
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
Marius M Hoeper, Gérald Simonneau, Paul A Corris, et al.
JACC. Heart Failure
|
May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and Mortality
Charles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 17, 2009
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease
Kari E Roberts, Michael B Fallon, Michael J Krowka, et al.
Pulmonary Circulation
|
November 18, 2021
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
Robert P Frantz, Raymond L Benza, Richard N Channick, et al.
Pulmonary Circulation
|
October 11, 2024
PPARγ/ETV2 axis regulates endothelial-to-mesenchymal transition in pulmonary hypertension
Dong Hun Lee, Minseong Kim, Sarah S Chang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 5, 2018
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study
Adaani Frost, Munir Janmohamed, Jason S Fritz, et al.
Journal of the American College of Cardiology
|
September 2, 2024
Impact of Renal and Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair
Ulrich P Jorde, Raymond Benza, Patrick M McCarthy, et al.
Circulation
|
March 19, 2003
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
Timothy D Henry, Brian H Annex, George R McKendall, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 22, 2019
Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases
Adam Torbicki, Marisa Bacchi, Marion Delcroix, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 362) with videos related to
Sort By:
Page
of 37
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 9, 2024
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study
Raymond L Benza, Gérald Simonneau, Hossein-Ardeschir Ghofrani, et al.
The European Respiratory Journal
|
September 11, 2017
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
Marius M Hoeper, Gérald Simonneau, Paul A Corris, et al.
JACC. Heart Failure
|
May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and Mortality
Charles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 17, 2009
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease
Kari E Roberts, Michael B Fallon, Michael J Krowka, et al.
Pulmonary Circulation
|
November 18, 2021
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
Robert P Frantz, Raymond L Benza, Richard N Channick, et al.
Pulmonary Circulation
|
October 11, 2024
PPARγ/ETV2 axis regulates endothelial-to-mesenchymal transition in pulmonary hypertension
Dong Hun Lee, Minseong Kim, Sarah S Chang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 5, 2018
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study
Adaani Frost, Munir Janmohamed, Jason S Fritz, et al.
Journal of the American College of Cardiology
|
September 2, 2024
Impact of Renal and Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair
Ulrich P Jorde, Raymond Benza, Patrick M McCarthy, et al.
Circulation
|
March 19, 2003
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
Timothy D Henry, Brian H Annex, George R McKendall, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 22, 2019
Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases
Adam Torbicki, Marisa Bacchi, Marion Delcroix, et al.
Page
of 37